Immunogenicity of a Heterologous Prime-Boost COVID-19 Vaccination with mRNA and Inactivated Virus Vaccines Compared with Homologous Vaccination Strategy against SARS-CoV-2 Variants

por Zhang, Ruiqi, Liu, Danlei, Leung, Ka-Yi, Fan, Yujing, Lu, Lu, Chan, Pui-Chun, To, Kelvin Kai-Wang, Chen, Honglin, Yuen, Kwok-Yung, Chan, Kwok-Hung, Hung, Ivan Fan-Ngai
Publicado 2022

Correlation of Immunogenicity and Reactogenicity of BNT162b2 and CoronaVac SARS-CoV-2 Vaccines

por Zhang, Ruiqi, Leung, Ka-Yi, Liu, Danlei, Fan, Yujing, Lu, Lu, Chan, Pui-Chun, To, Kelvin Kai-Wang, Chen, Honglin, Yuen, Kwok-Yung, Chan, Kwok-Hung, Hung, Ivan Fan-Ngai
Publicado 2022

Antibody Response of BNT162b2 and CoronaVac Platforms in Recovered Individuals Previously Infected by COVID-19 against SARS-CoV-2 Wild Type and Delta Variant

por Zhang, Ruiqi, Khong, Ka-Wa, Leung, Ka-Yi, Liu, Danlei, Fan, Yujing, Lu, Lu, Chan, Pui-Chun, Chen, Linlei, To, Kelvin Kai-Wang, Chen, Honglin, Yuen, Kwok-Yung, Chan, Kwok-Hung, Hung, Ivan Fan-Ngai
Publicado 2021

Antibody Response of Combination of BNT162b2 and CoronaVac Platforms of COVID-19 Vaccines against Omicron Variant

por Khong, Ka-Wa, Liu, Danlei, Leung, Ka-Yi, Lu, Lu, Lam, Hoi-Yan, Chen, Linlei, Chan, Pui-Chun, Lam, Ho-Ming, Xie, Xiaochun, Zhang, Ruiqi, Fan, Yujing, To, Kelvin Kai-Wang, Chen, Honglin, Yuen, Kwok-Yung, Chan, Kwok-Hung, Hung, Ivan Fan-Ngai
Publicado 2022